Cefixime Capsule
NDC Package 70518-3221-0

11-digit billing NDC: 70518322100

Package Information

Cefixime capsules is table 3. This formulation utilizes a capsule delivery system. Marketed by Remedyrepack Inc., this product is identified by NDC 70518-3221 and is authorized under FDA application NDA203195.

Identification & Billing

NDC Package Code
70518-3221-0
Package Description
2 POUCH in 1 BOX / 1 CAPSULE in 1 POUCH (70518-3221-1)
Product Code
11-Digit Billing Format
70518322100
RxNorm Crosswalk
RxCUI: 409823 - cefixime 400 MG Oral Capsule

Clinical Specifications

Proprietary Name
Cefixime
Non-Proprietary Name
Cefixime
Substance Name
Cefixime
Dosage Form
Capsule - A solid oral dosage form consisting of a shell and a filling. The shell is composed of a single sealed enclosure, or two halves that fit together and which are sometimes sealed with a band. Capsule shells may be made from gelatin, starch, or cellulose, or other suitable materials, may be soft or hard, and are filled with solid or liquid ingredients that can be poured or squeezed.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
Table 3. Reconstitution Direction for Cefixime for Oral SuspensionStrengthBottleSizeReconstitutionDirections200 mg/5 mL 75 mL To reconstitute, suspend with 51mLwater. Method: Tap the bottle several times to loosen powder contents prior to reconstitution. Add approximately half the total amount of water for reconstitution and shake well. Add the remainder of water and shake well. 100 mg/5 mL and 200 mg/5 mL 50 mL To reconstitute, suspend with 34mLwater. Method: Tap the bottle several times to loosen powder contents prior to reconstitution. Add approximately half the total amount of water for reconstitution and shake well. Add the remainder of water and shake well. After reconstitution, the suspension may be kept for 14 days either at room temperature, or under refrigeration, without significant loss of potency. Keep tightly closed. Shake well before using. Discard unused portion after 14 days.

Regulatory & Marketing

Labeler Name
Remedyrepack Inc.
Product Type
Human Prescription Drug
FDA Application #
NDA203195
Marketing Category
NDA AUTHORIZED GENERIC - A product marketed as a "generic" drug under an approved New Drug Application (NDA), rather than an Abbreviated New Drug Application (ANDA),.
Start Marketing Date
09-14-2021
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (70518-3221). Click a package code to view its specific billing and regulatory data.

2 POUCH in 1 BOX / 1 CAPSULE in 1 POUCH (70518-3221-3)
2 CAPSULE in 1 BOTTLE, PLASTIC
2 CAPSULE in 1 BOTTLE, PLASTIC

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70518-3221-0 identifies a specific commercial package of 2 pouch in 1 box / 1 capsule in 1 pouch (70518-3221-1) of Cefixime, a human prescription drug labeled by Remedyrepack Inc.. This capsule is formulated for oral use and contains cefixime as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Remedyrepack Inc. on September 14, 2021. The current certification is valid through December 31, 2027.

How is this Remedyrepack Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70518322100. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
70518-3221-0
11-Digit CMS (5-4-2)
70518-3221-00

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.